Clinical Neuroradiology, Год журнала: 2024, Номер 34(1), С. 33 - 43
Опубликована: Янв. 26, 2024
Язык: Английский
Clinical Neuroradiology, Год журнала: 2024, Номер 34(1), С. 33 - 43
Опубликована: Янв. 26, 2024
Язык: Английский
Cells, Год журнала: 2023, Номер 12(23), С. 2670 - 2670
Опубликована: Ноя. 21, 2023
Background: Gliomas are the most malignant tumors of central nervous system. One factors in their high drug resistance is avoiding programmed death (PCD) induction. This related to overexpression intracellular survival pathways: PI3K-Akt/PKB-mTOR and Ras-Raf-MEK-ERK. Apoptosis autophagy co-existing processes due interactions between Bcl-2 beclin-1 proteins. Their complex may be a molecular “toggle-switch” PCD types. The aim this research was investigate role Bcl-2:beclin-1 glioma cell elimination through combined action LY294002 sorafenib. Methods: Drug cytotoxicity estimated with an MTT test. type evaluated using variant microscopy techniques (fluorochrome staining, immunocytochemistry, transmission electron microscopy), as well formation protein localization. Molecular analysis indicators conducted immunoblotting, immunoprecipitation, ELISA testing. SiRNA used block expression. Results: results showed inhibitors simultaneous application resulted apoptosis becoming dominant. accompanied by changes location tested Conclusions: “Switching” PI3K Raf opens new therapeutic perspectives against gliomas.
Язык: Английский
Процитировано
12Oncogene, Год журнала: 2023, Номер 42(16), С. 1308 - 1320
Опубликована: Март 7, 2023
Язык: Английский
Процитировано
11Cancer, Год журнала: 2023, Номер 129(19), С. 3010 - 3022
Опубликована: Май 28, 2023
Abstract Background Glioblastoma (GBM) is the most common malignant primary brain tumor. Emerging reports have suggested that racial and socioeconomic disparities influence outcomes of patients with GBM. No studies to date investigated these controlling for isocitrate dehydrogenase (IDH) mutation O‐6‐methylguanine‐DNA methyltransferase (MGMT) status. Methods Adult GBM were retrospectively reviewed at a single institution from 2008 2019. Univariable multivariable complete survival analyses performed. A Cox proportional hazards model was used assess effect race status priori selected variables known relevance survival. Results In total, 995 met inclusion criteria. Of these, 117 (11.7%) African American (AA). The median overall entire cohort 14.23 months. model, AA had better compared White (hazard ratio [HR], 0.37; 95% confidence interval [CI], 0.2–0.69). observed difference significant in both case analysis multiple imputations accounting missing molecular data treatment low income (HR, 2.17; CI, 1.04–4.50), public insurance 2.25; 1.04–4.87), or no 15.63; 2.72–89.67) worse income, insurance, respectively. Conclusions Significant identified after treatment, genetic profile, other associated Overall, demonstrated These findings may suggest possibility protective advantage patients. Plain Language Summary To best personalize understand causes glioblastoma, influences must be examined. authors report their experience O’Neal Comprehensive Cancer Center deep south. this report, contemporary diagnostic are included. conclude there glioblastoma outcome do better.
Язык: Английский
Процитировано
11Journal of the Neurological Sciences, Год журнала: 2023, Номер 452, С. 120762 - 120762
Опубликована: Авг. 2, 2023
Язык: Английский
Процитировано
11Clinical Neuroradiology, Год журнала: 2024, Номер 34(1), С. 33 - 43
Опубликована: Янв. 26, 2024
Язык: Английский
Процитировано
4